Tubitere Novo 20mg Injection

Prezentare produs

About Tubitere Novo

Tubitere Novo is a medication containing the active ingredient Docetaxel, classified as Microtubule Inhibitor. Docetaxel, sold under the brand name Taxotere among others, is a chemotherapy medication used to treat a number of types of cancer. This includes breast cancer, head and neck cancer, stomach cancer, prostate cancer and non-small-cell lung cancer. It may be used by itself or along with other chemotherapy medication.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Docetaxel Injection is a microtubule inhibitor indicated for: • Breast Cancer (BC): single agent for locally advanced or.
• Used for: and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC ( 1
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Docetaxel, the active ingredient in Tubitere Novo, belongs to the Microtubule Inhibitor class. 1 INDICATIONS AND USAGE Docetaxel Injection is a microtubule inhibitor indicated for: • Breast Cancer (BC): single agent for locally advanced or metastatic BC after chemotherapy failure; and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node-positive BC ( 1. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Tubitere Novo. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Tubitere Novo for extended periods without medical advice.